课题基金 / 基金详情

IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

IGF::OT::IGF R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
IGF::OT::IGF R
批准号:
9355301
负责人:
NALIN KUMAR
金额:
$75.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2017-09-14

项目摘要

项目成果

NALIN KUMAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this SBIR Phase II contract is to develop an inexpensive and easy to use instrument that will be capable of measuring low ppm levels (at least <5 ppm) of a range of metals typically used in the pharmaceutical industry. The instrument would be co-located with the reaction and purification equipment where metal removal is performed, and preferably, amenable to continuous monitoring of metal impurities associated with continuous processing operations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE PURPOSE OF THE CONTRACT IS TO DEVELOP A NOVEL, HIGH-INTENSITY VERSION OF A D
  • 批准号:
    8356544
  • 项目类别:
  • 资助金额:
    $24.45万
  • 财政年份:
    2011
  • 负责人:
    NALIN KUMAR
  • 依托单位:
A Two Hybrid System Based Yeasy Screen for Agents that Affect DNA Damage Checkpoi
  • 批准号:
    7326735
  • 项目类别:
  • 资助金额:
    $13.54万
  • 财政年份:
    2007
  • 负责人:
    NALIN KUMAR
  • 依托单位:
海外基金